Aim
To prospectively evaluate the predictive value of pre-treatment histogram analysis of apparent diffusion coefficients (ADC) at whole body diffusion-weighted imaging (WB-DWI/MRI) for patient outcome in primary ovarian cancers.
Methods
Institutional review board approval and informed consent were obtained for this prospective study. Forty-four women diagnosed with FIGO stage III or IV ovarian carcinoma underwent 3-Tesla WB-DWI/MRI using 2 b-values (b=0-1000 s/mm2), T2-weighted and contrast-enhanced T1-weighted sequences prior to treatment. The primary tumour was delineated using semi-automated software and was analysed by using an ADC histogram approach: mean and median ADC, standard deviation (SD), coefficient of variation (CoV, SD/mean), kurtosis and skewness were calculated. Kaplan-Meier with log-rank statistics were used to correlate baseline ADC parameters to disease free survival (DFS). Effects of confounding patients- and tumour-related factors were taken into consideration using Cox proportional hazard model.
Results
5 patients underwent primary- and 39 interval debulking surgery completing 6 cycles of platinum-based chemotherapy. Survival analyses showed that lower CoV was associated with significantly longer DFS (median ± SD; 19±2 months for CoV<0.2601 versus 12±1 months for CoV>0.2601; p=0.002). After multivariable analysis, CoV remained an independent prognostic biomarker for DFS (p=0.003) when taking patient’s age, FIGO stage, tumour grade and cancer antigen (CA)-125 level into consideration as clinical prognostic factors.
Conclusion
In this pilot study, pre-treatment ADC histogram analysis of primary ovarian cancer using the CoV was an independent predictive marker of DFS suggesting a correlation between tumour heterogeneity and treatment resistance. Further research should elucidate the correlation with overall survival.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Michielsen, K., Vergote, I., Amant, F. et al. Pre-treatment ADC histogram-analysis at whole body diffusion-weighted MRI predicts disease free survival in ovarian cancer. Cancer Imaging 15 (Suppl 1), S5 (2015). https://doi.org/10.1186/1470-7330-15-S1-S5
Published:
DOI: https://doi.org/10.1186/1470-7330-15-S1-S5